DVT prophylaxis in orthopaedic oncology patients - A safety study.

Trial Profile

DVT prophylaxis in orthopaedic oncology patients - A safety study.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Deep vein thrombosis
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Sep 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
    • 12 Sep 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 11 Sep 2015 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top